The purpose of our study was to evaluate the contribution of an automated drug dispensing system in securing cancer chemotherapy production process at the pharmacy of the National Institute of Oncology in Rabat.
Methods
The failure modes and effects analysis method was applied to the chemotherapy production process in two phases: Phase 1, using an open shelf for storage then phase 2, using an automated drug dispensing system. The failure modes were defined and their criticality indexes was calculated on the basis of the likelihood of occurrence, the potential severity for the patients and/or the impact on the process and the detection probability. The criticality indexes of the two phases were prioritized and compared.
Results
We identified 35 failure modes for phase 1 and 37 for phase 2. The sum of criticality indexes was 5957 and 4586, respectively, for phase 1 and phase 2, corresponding to a criticality reduction of −23%. The greatest improvements concerned that the needed drug is missing during the picking, storage of potential expired drugs, and double compounding.
Conclusion
Our study highlighted the contribution of automated drug dispensing system in risk minimization. The use of automated drug dispensing system is a part of security improvement in chemotherapy production unit.
SarsiEMBenabbesMEl HarrassA, et al.
Development of an alternative manual traceability system in the case of computer system malfunction and risk analysis using FMECA method: case of a central unit for cytotoxic preparation. J Pharm Clin2019;
38: 91–100.
ChapuisCRoustitMBalG, et al.
Automated drug dispensing system reduces medication errors in an intensive care setting. Crit Care Med2010;
38: 2275–2281.
4.
NicolasH. Sécurisation du circuit hospitalier de préparation des chimiothérapies: application de l’analyse de risque a priori. Sciences pharmaceutiques. HAL Id:dumas-01496003, https://dumas.ccsd.cnrs.fr/dumas-01496003/document.(2017, accessed 8 March 2020) [French].
5.
BonnabryP.Information technologies for the prevention of medication errors. Chim Int J Chem2005;
59: 359–361.
6.
AshokkumarRSrinivasamurthySKellyJ, et al.
Frequency of chemotherapy medication errors: a systematic review. J Pharma Pharm2018;
9: 86–91.
7.
WhiteRCassano-PichéAFieldsA, et al.
Intravenous chemotherapy preparation errors: patient safety risks identified in a pan-Canadian exploratory study.J Oncol Pharm Pract2014;
20: 40–46.
8.
BonnabryPCingriaLAckermannM, et al.
Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process.Int J Qual Health Care2006;
18: 9–16.
9.
FarmerP FJKnaulFM, et al.
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet2010;
376: 1186–1193.
10.
BrayF FJSoerjomataramI, et al.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.Cancer J Clin2018;
68: 394–424.
CarrezLBouchoudLFleuryS, et al.
Work overload is related to increased risk of error during chemotherapy preparation. J Oncol Pharm Pract2019;
25: 1456–1466.
13.
LimatSDrouhinJDemesmayK, et al.
Incidence and risk factors of preparation errors in a centralized cytotoxic preparation unit. Pharm World Sci2001;
23: 102–106.
14.
AdadeCABenabbesMBelahcenMJ, et al.
Centralization impact and cost-saving study in a Moroccan hospital's centralized unit of chemotherapy preparation. J Oncol Pharm Pract2020. Published as OnlineFirst DOI: 10.1177/1078155220901336
15.
BonnabryPDespont-GrosCGrauserD, et al.
A risk analysis method to evaluate the impact of a computerized provider order entry system on patient safety.Am Med Inform Assoc2008;
15: 453–460.
16.
DjermouneSOukkalMBouzidK, et al.
Utilisation d’une méthode d’analyse prospective des risques pour améliorer la sécurité du processus chimiothérapie anticancéreuse dans un service d’oncologie médicale en Algérie.Le Pharm Hosp Clin2016;
51: 40–50. [French]
17.
ChryslerLMotorsG.Potential failure mode and effect analysis (FMEA): reference manual. United States of America:Edisi Ke-4 Ford Motor Company, 2008.
18.
AlouRHartiJ.Mapping risk management in predisinfection of medical devices in a hospital environment. The example of the central sterilization laboratory of the Ibn Sina Hospital, Rabat, Morocco. Le Pharm Hosp Clin2018; 53: 279–287.
19.
BouléMLachapelleaSCollin-LévesqueaL, et al. A commented step-by-step approach to realize a FMEA as part of the drug circuit. Le Pharm Hosp Clin2018; 53: 315–324.
20.
KhenieneFBedouchPDurandM, et al.
Economic impact of an automated dispensing system in an intensive care unit.Ann Franc d'anesth Reanim2008;
27: 208–215.
21.
JamesKLBarlowDBithellA, et al.
The impact of automation on workload and dispensing errors in a hospital pharmacy. Int J Pharm Pract2013;
21: 92–104.
22.
CouseinEMarevilleJLerooyA, et al.
Effect of automated drug distribution systems on medicationerror rates in a short-stay geriatric unit: drug distribution and medication error. Eval Clin Pract2014;
20: 678—684.
23.
CarrezLBouchoudLFleury-SouverainS, et al.
Reliability of chemotherapy preparation processes: evaluating independent double-checking and computer-assisted gravimetric control. J Oncol Pharm Pract2017;
23: 83–92.
24.
Le GarlantézecPAupéeOBohandX, et al.
Choix et mise en place d’un contrôle pondéral libératoire au sein d’une unité hospitalière centralisée de préparation des cytotoxiques. Le Pharm Hosp2008;
43: 19–27. [French]
25.
DeldicqueABourhisMCadotC, et al.
Analyse des différentes méthodes de contrôle des chimiothérapies: quel choix pour un centre hospitalier général?Le Pharm Hosp Clin2016;
51: 85–86. [French]
26.
CazinJLGosselinP.Implementing a multiple‐isolator unit for centralized preparation of cytotoxic drugs in a cancer center pharmacy. Pharm World Sci1999;
21: 177–183.
27.
CheungK-CVan Den BemtPMBouvyML, et al.
Medication incidents related to automated dose dispensing in community pharmacies and hospitals-a reporting system study. PLoS One2014;
9: e101686.
